Our Tailored Services
BioPharma Investors
Scientific Deep-Dive on Investment Case
An investment fund explores investing into a clinical stage biotech developing a novel anti-cancer drug, requiring a deep science-driven asset-market fit analysis.
Case Study
By integrating comprehensive disease genomics, clinical data, patient demographics, scientific literature, and market trends, we create a robust and dynamic analysis platform. Here, we systematically evaluate the investment case based on scientific validity, clinical need, and commercial viability. Detailed analyses follow, offering actionable insights and strategic recommendations, ultimately resulting in high-impact investments that address real unmet medical needs.
Approach by NicinBio Strategy
Scientific Due Diligence
A life sciences fund evaluates a potential investment for an innovative therapeutic for a cardiovascular disease, requiring deep scientific DD to ensure high-potential.
Case Study
We support scientific/technical and commercial due diligence processes, ensuring a meticulous assessment of potential risks. Our team evaluates the mechanism of action, focuses on scientific rationale, ranks relevant competitors, compares development timelines and regulatory requirements and models market sizes and commercial opportunities. The output supports the team to guide their investment hypothesis.
Approach by NicinBio Strategy
